Post-Market Surveillance in Medical Devices
Post-market surveillance in medical devices has become a defining feature of the U.S. regulatory environment, reflecting a shift from episodic compliance to continuous lifecycle oversight. As device innovation accelerates across digital health, implantables, and AI-enabled diagnostics, regulators expect manufacturers to maintain active visibility into product safety and performance long after market entry. For medical technology … Read more